Mark Froimson - 12 Aug 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
12 Aug 2024
Net transactions value
+$16,212
Form type
4
Filing time
12 Aug 2024, 20:33:26 UTC
Previous filing
13 Jun 2024
Next filing
13 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Purchase $16,212 +1,400 +11% $11.58 14,473 12 Aug 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.